Official Title
Outpatient and Home Pulmonary Rehabilitation Program for Post COVID-19 Patients
Brief Summary

Coronavirus-2019 disease (COVID-19) is a highly infectious respiratory disease that causes respiratory, physical and psychological dysfunction in patients. With the increased understanding of the severity of COVID-19 and clinical evidence in accordance with the opinions of first-line clinical experts involved in the treatment of this epidemic, the investigators believe that the participation of patients with sequelae of COVID-19 in a Pulmonary Rehabilitation Program would be of utmost importance. According to recent scientific recommendations for patients with sequelae of COVID-19, respiratory rehabilitation would alleviate symptoms of dyspnea, anxiety and depression and, eventually, improve physical functions and quality of life. Therefore, it is essential to anticipate early rehabilitation after the acute phase of ARDS, in order to limit the severity of the effects of the ICU and promote rapid functional recovery. Physiotherapy will play a role in providing exercise, mobilization and rehabilitation interventions for survivors of critical illnesses associated with COVID-19, in order to enable a functional social return.

Detailed Description

The investigatores propose a clinical, prospective and consecutive study composed of
participants with pulmonary sequelae of COVID-19 and pulmonary diseases such as COPD, Asthma,
Bronchitis, Emphysema, Bronchiectasis and pulmonary fibrosis. Initially, all patients will
undergo a physical assessment, pulmonary function tests and nutritional assessment, in
addition to applying the modified dyspnea scale of the MMRC (Modified Medical Research
Council) and the 6-minute walk test (6MWT), according to the standards recommended by the
American Thoracic Society (ATS).

The proposed Outpatient and Home Pulmonary Rehabilitation Program is based on the Guidelines
recommended by the Brazilian Society of Pulmonology (SBPT) and by the Global Initiative for
Chronic Obstructive Lung Disease (GOLD), with a minimum duration of 12 weeks, frequency of 3
weekly sessions, accompanied by health professionals in this field.

Patients who seek care at municipal and state health services in the city of Anápolis,
(Goiás) will be recruited. Patients with clinically stabilized COVID - 19 sequelae will be
considered eligible, and who agree to participate in the study, signing the Informed Consent
.

The outpatient PRP consisted of a combination of aerobic and strengthening exercises, lasting
12 weeks, frequency 3 times a week. Each session will consist of active warm-up exercises,
upper and lower limb strengthening, aerobic conditioning and stretching exercises. The
warm-up phase consists of intercalated calisthenic exercises for different muscle groups,
according to each patient's tolerance.

Unknown status
COVID19
COVID-19 Respiratory Infection
Lung Diseases
Respiratory Insufficiency
Muscle Weakness
Anxiety Disorder; Mixed With Depression (Mild)

Other: Pulmonary Rehabilitation

The Pulmonary Rehabilitation Program consists of a combination of aerobic and strengthening exercises, lasting 12 weeks, with a frequency of 3 times a week, always in the morning. Each session consists of active warm-up exercises, upper and lower limb strengthening, aerobic conditioning and stretching exercises. The warm-up phase consists of intercalated calisthenic exercises for different muscle groups, according to each patient's tolerance.

Eligibility Criteria

Inclusion Criteria:

- Patients with a diagnosis of pulmonary sequelae post COVID-19

- Patients clinically stabilized

- Who agreed to participate in the clinical study, signing the informed consent form,
will be considered eligible.

Exclusion Criteria:

- Hospitalized patients

- Patients who present clinical instability

- Patients who do not commit to adhering to the Pulmonary Rehabilitation Program

Eligibility Gender
All
Eligibility Age
Minimum: 16 Years ~ Maximum: N/A
Countries
Brazil
Locations

Centro Universitário de Anápolis - UniEVANGÉLICA
Anápolis, GO, Brazil

Investigator: Luis VF Oliveira, PhD
Contact: +55 62 33106600
oliveira.lvf@gmail.com

Contacts

Luis LV Oliveira, PhD
0055 62 999052309
oliveira.lvf@gmail.com

Luis VF Oliveira, PhD
0055 62 999052309
luis.oliveira@unievangelica.edu.br

Luis VF OLiveira, PhD, Principal Investigator
Evangelical University of Goiás - UNIEVANGELICA

Centro Universitário de Anapolis
NCT Number
Keywords
Covid-19
pulmonary rehabilitation
Pulmonary Function
Respiratory Physiotherapy
Respiratory insufficiency
MeSH Terms
COVID-19
Respiratory Tract Infections
Muscle Weakness
Lung Diseases
Respiratory Insufficiency
Anxiety Disorders